← Open Payments lookup

SHAHRIAR JARCHI: Open Payments

NPI 1417008772 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$352 in 12 payments from 9 companies in 2025. Trend: 2023 $427 · 2024 $96 · 2025 $352

Food & beverage: $352
CompanyPaymentsAmount
Novo Nordisk Inc2$63
Lundbeck LLC2$62
ABBVIE INC.2$59
MERZ NORTH AMERICA, INC.1$34
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$31
Lilly USA, LLC1$30
Otsuka America Pharmaceutical, Inc.1$28
Noven Therapeutics, LLC1$24
Exact Sciences Corporation1$22

Products named: REXULTI, UBRELVY, Xeomin, Wegovy, CAPLYTA, Ozempic, MOUNJARO, Xelstrym.

Industry payments across CA — which companies pay providers there.